{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T19:51:42Z","timestamp":1790970702084,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1124\/mol.108.048207","type":"journal-article","created":{"date-parts":[[2008,7,12]],"date-time":"2008-07-12T01:36:08Z","timestamp":1215826568000},"page":"980-989","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":98,"title":["Paraxanthine, the Primary Metabolite of Caffeine, Provides Protection against Dopaminergic Cell Death via Stimulation of Ryanodine Receptor Channels"],"prefix":"10.1016","volume":"74","author":[{"given":"Serge","family":"Guerreiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Toulorge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Marien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Sokoloff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick P.","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/mol.108.048207_REF1","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/0140-6736(91)92989-F","article-title":"Parkinson\u2019s disease: pathophysiology","volume":"337","author":"Agid","year":"1991","journal-title":"Lancet"},{"key":"10.1124\/mol.108.048207_REF2","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.pbb.2006.05.027","article-title":"Neuroprotective effects of caffeine in the model of 6-hydroxydopamine lesion in rats","volume":"84","author":"Aguiar","year":"2006","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/mol.108.048207_REF3","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/ana.1052","article-title":"Prospective study of caffeine consumption and risk of Parkinson\u2019s disease in men and women","volume":"50","author":"Ascherio","year":"2001","journal-title":"Ann Neurol"},{"issue":"Suppl 1","key":"10.1124\/mol.108.048207_REF4","first-page":"S297","article-title":"Drugs for asthma","volume":"147","author":"Barnes","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.108.048207_REF5","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0306-4522(02)00222-1","article-title":"Cyclic AMP differentially regulates the expression of fibroblast growth factor and epidermal growth factor receptors in cultured cortical astroglia","volume":"114","author":"Bayatti","year":"2002","journal-title":"Neuroscience"},{"key":"10.1124\/mol.108.048207_REF6","doi-asserted-by":"crossref","first-page":"12176","DOI":"10.1074\/jbc.273.20.12176","article-title":"Structure-function relationships among ryanodine derivatives. Pyridyl ryanodine definitively separates activation potency from high affinity","volume":"273","author":"Bidasee","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.108.048207_REF7","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1007\/s00018-007-7051-9","article-title":"Caffeine analogs: biomedical impact","volume":"64","author":"Daly","year":"2007","journal-title":"Cell Mol Life Sci"},{"key":"10.1124\/mol.108.048207_REF8","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1046\/j.1471-4159.2001.00401.x","article-title":"Survival promotion of mesencephalic dopaminergic neurons by depolarizing concentrations of K+ requires concurrent inactivation of NMDA or AMPA\/kainate receptors","volume":"78","author":"Douhou","year":"2001","journal-title":"J Neurochem"},{"key":"10.1124\/mol.108.048207_REF9","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0014-2999(90)90168-6","article-title":"Paraxanthine displaces the binding of [3H]SCH 23390 from rat striatal membranes","volume":"179","author":"Ferr\u00e9","year":"1990","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/mol.108.048207_REF10","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1152\/physrev.00013.2002","article-title":"Ryanodine receptor calcium release channels","volume":"82","author":"Fill","year":"2002","journal-title":"Physiol Rev"},{"key":"10.1124\/mol.108.048207_REF11","doi-asserted-by":"crossref","first-page":"26965","DOI":"10.1074\/jbc.272.43.26965","article-title":"Dantrolene inhibition of sarcoplasmic reticulum Ca2+ release by direct and specific action at skeletal muscle ryanodine receptors","volume":"272","author":"Fruen","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.108.048207_REF12","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0166-4328(01)00418-1","article-title":"Intrinsic membrane properties and synaptic inputs regulating the firing activity of the dopamine neurons","volume":"130","author":"Grillner","year":"2002","journal-title":"Behav Brain Res"},{"key":"10.1124\/mol.108.048207_REF13","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1001\/archneur.64.4.576","article-title":"Smoking, caffeine, and nonsteroidal anti-inflammatory drugs in families with Parkinson disease","volume":"64","author":"Hancock","year":"2007","journal-title":"Arch Neurol"},{"key":"10.1124\/mol.108.048207_REF14","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1152\/jappl.2000.89.6.2312","article-title":"Paraxanthine, a caffeine metabolite, dose dependently increases [Ca2+]i in skeletal muscle","volume":"89","author":"Hawke","year":"2000","journal-title":"J Appl Physiol"},{"key":"10.1124\/mol.108.048207_REF15","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nrd1983","article-title":"Adenosine receptors as therapeutic targets","volume":"5","author":"Jacobson","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/mol.108.048207_REF16","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/0378-4347(87)80463-2","article-title":"Pharmacokinetics of intravenous caffeine: comparison of high-performance liquid chromatographic and gas chromatographic methods","volume":"422","author":"Kennedy","year":"1987","journal-title":"J Chromatogr"},{"key":"10.1124\/mol.108.048207_REF17","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1371\/journal.pbio.0050039","article-title":"Absence of Ret signaling in mice causes progressive and late degeneration of the nigrostriatal system","volume":"5","author":"Kramer","year":"2007","journal-title":"PLoS Biol"},{"key":"10.1124\/mol.108.048207_REF18","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/mds.1246","article-title":"Toxicity of Annonaceae for dopaminergic neurons: potential role in atypical parkinsonism in Guadeloupe","volume":"17","author":"Lannuzel","year":"2002","journal-title":"Mov Disord"},{"key":"10.1124\/mol.108.048207_REF19","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0022-3565(25)23651-5","article-title":"Paraxanthine metabolism in humans: determination of metabolic partial clearances and effects of allopurinol and cimetidine","volume":"248","author":"Lelo","year":"1989","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.108.048207_REF20","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1126\/science.8493557","article-title":"GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons","volume":"260","author":"Lin","year":"1993","journal-title":"Science"},{"key":"10.1124\/mol.108.048207_REF21","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1212\/01.WNL.0000072330.07328.D6","article-title":"Parkinsonian signs in older people: prevalence and associations with smoking and coffee","volume":"61","author":"Louis","year":"2003","journal-title":"Neurology"},{"key":"10.1124\/mol.108.048207_REF22","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nm0705-703","article-title":"Glial cell line-derived neurotrophic factor induces neuronal sprouting in human brain","volume":"11","author":"Love","year":"2005","journal-title":"Nat Med"},{"key":"10.1124\/mol.108.048207_REF23","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1385\/CBB:40:2:207","article-title":"Membrane topology and membrane retention of the ryanodine receptor calcium release channel","volume":"40","author":"Ma","year":"2004","journal-title":"Cell Biochem Biophys"},{"key":"10.1124\/mol.108.048207_REF24","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1080\/1040-830491379245","article-title":"Caffeine use in sports, pharmacokinetics in man, and cellular mechanisms of action","volume":"45","author":"Magkos","year":"2005","journal-title":"Crit Rev Food Sci Nutr"},{"key":"10.1124\/mol.108.048207_REF25","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1471-4159.2006.04424.x","article-title":"Role of activity-dependent mechanisms in the control of dopaminergic neuron survival","volume":"101","author":"Michel","year":"2007","journal-title":"J Neurochem"},{"key":"10.1124\/mol.108.048207_REF26","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/jnr.490400608","article-title":"Death of septal cholinergic neurons produced by chronic exposure to glutamate is prevented by the noncompetitive NMDA receptor\/channel antagonist, MK-801: role of nerve growth factor and nitric oxide","volume":"40","author":"Michel","year":"1995","journal-title":"J Neurosci Res"},{"key":"10.1124\/mol.108.048207_REF27","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1046\/j.1471-4159.1996.67041633.x","article-title":"Chronic activation of the cyclic AMP signaling pathway promotes development and long-term survival of mesencephalic dopaminergic neurons","volume":"67","author":"Michel","year":"1996","journal-title":"J Neurochem"},{"key":"10.1124\/mol.108.048207_REF28","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1046\/j.1471-4159.1999.0722074.x","article-title":"Adenosine prevents the death of mesencephalic dopaminergic neurons by a mechanism that involves astrocytes","volume":"72","author":"Michel","year":"1999","journal-title":"J Neurochem"},{"key":"10.1124\/mol.108.048207_REF29","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1046\/j.1471-4159.1997.69041499.x","article-title":"Rescue of mesencephalic dopamine neurons by anticancer drug cytosine arabinoside","volume":"69","author":"Michel","year":"1997","journal-title":"J Neurochem"},{"key":"10.1124\/mol.108.048207_REF30","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1124\/mol.64.3.578","article-title":"Prevention of dopaminergic neuronal death by cyclic AMP in mixed neuronal\/glial mesencephalic cultures requires the repression of presumptive astrocytes","volume":"64","author":"Mourlevat","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.108.048207_REF31","first-page":"1378","article-title":"Relationship between caffeine intake and Parkinson disease","volume":"284","author":"Ross","year":"2000","journal-title":"Jama"},{"key":"10.1124\/mol.108.048207_REF32","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1046\/j.1460-9568.1999.00650.x","article-title":"Release of endogenous dopamine in cultured mesencephalic neurons: influence of dopaminergic agonists and glucocorticoid antagonists","volume":"11","author":"Roug\u00e9-Pont","year":"1999","journal-title":"Eur J Neurosci"},{"key":"10.1124\/mol.108.048207_REF33","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/sj.ejcn.1602788","article-title":"Prospective study of coffee consumption and risk of Parkinson\u2019s disease","volume":"62","author":"S\u00e4\u00e4ksj\u00e4rvi","year":"2008","journal-title":"Eur J Clin Nutr"},{"key":"10.1124\/mol.108.048207_REF34","doi-asserted-by":"crossref","first-page":"5922","DOI":"10.1523\/JNEUROSCI.5668-03.2004","article-title":"Rescue of mesencephalic dopaminergic neurons in culture by low-level stimulation of voltage-gated sodium channels","volume":"24","author":"Salthun-Lassalle","year":"2004","journal-title":"J Neurosci"},{"key":"10.1124\/mol.108.048207_REF35","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1124\/mol.106.022715","article-title":"The phenotypic differentiation of locus ceruleus noradrenergic neurons mediated by brain-derived neurotrophic factor is enhanced by corticotropin releasing factor through the activation of a cAMP-dependent signaling pathway","volume":"70","author":"Traver","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.108.048207_REF36","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1124\/mol.62.5.1043","article-title":"Activation of the mitogen-activated protein kinase (ERK\u00bd) signaling pathway by cyclic AMP potentiates the neuroprotective effect of the neurotransmitter noradrenaline on dopaminergic neurons","volume":"62","author":"Troadec","year":"2002","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.108.048207_REF37","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1152\/physrev.00004.2004","article-title":"Physiology and pathophysiology of the calcium store in the endoplasmic reticulum of neurons","volume":"85","author":"Verkhratsky","year":"2005","journal-title":"Physiol Rev"},{"key":"10.1124\/mol.108.048207_REF38","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0304-3940(02)00069-1","article-title":"Caffeine\u2019s neuroprotection against 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine toxicity shows no tolerance to chronic caffeine administration in mice","volume":"322","author":"Xu","year":"2002","journal-title":"Neurosci Lett"},{"key":"10.1124\/mol.108.048207_REF39","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1523\/JNEUROSCI.3008-05.2006","article-title":"Estrogen prevents neuroprotection by caffeine in the mouse 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine model of Parkinson\u2019s disease","volume":"26","author":"Xu","year":"2006","journal-title":"J Neurosci"},{"key":"10.1124\/mol.108.048207_REF40","first-page":"487","article-title":"Neuroprotection by metabolites of caffeine may prolong its neuroprotective effect in the MPTP model of PD","volume":"28","author":"Xu","year":"2002","journal-title":"Soc Neurosci Abstr"},{"key":"10.1124\/mol.108.048207_REF41","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1146\/annurev.biochem.76.053105.094237","article-title":"Modulation of the ryanodine receptor and intracellular calcium","volume":"76","author":"Zalk","year":"2007","journal-title":"Annu Rev Biochem"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24145610?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24145610?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.108.048207","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T10:23:25Z","timestamp":1740047005000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24145610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S0026895X24145610"],"URL":"https:\/\/doi.org\/10.1124\/mol.108.048207","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Paraxanthine, the Primary Metabolite of Caffeine, Provides Protection against Dopaminergic Cell Death via Stimulation of Ryanodine Receptor Channels","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.108.048207","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2008 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}